This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Conagra Brands (CAG) Readies for Q2 Earnings: Things to Note
by Zacks Equity Research
Conagra Brands' (CAG) second-quarter performance is likely to have witnessed gains from pricing and the strength of the snacks category amid rising cost inflation.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Consumer Staples Names
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Entrada (TRDA) Down on Regulatory Update for DMD Candidate
by Zacks Equity Research
Entrada (TRDA) plunges on clinical hold notice from the FDA regarding its Investigational New Drug Application (IND) for Duchenne muscular dystrophy (DMD) candidate.
3 Companies Recently Unveiling New Buyback Programs
by Derek Lewis
In the face of a challenging economic backdrop in 2022, companies willing to dish out extra cash can be hard to find.
Is Rising Beef Prices a Boon for Plant-Based Meat Stocks?
by Ansuiya Mohta
Price hikes for meats like beef present more opportunities for plant-based meat companies. The trend bodes well for stocks like Conagra (CAG), Beyond Meat (BYND) and Kellogg (K).
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MOAT
Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for MOAT
Is the Options Market Predicting a Spike in Kellogg (K) Stock?
by Zacks Equity Research
Investors need to pay close attention to Kellogg (K) stock based on the movements in the options market lately.
Is First Trust NASDAQ Food & Beverage ETF (FTXG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FTXG
Kellogg (K) Tops Q3 Earnings Estimates, Raises 2022 Guidance
by Zacks Equity Research
Kellogg's (K) third-quarter 2022 results reflect increased sales due to the price/mix and solid momentum across snacks and emerging markets. However, earnings per share decline year over year.
Kellogg (K) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Kellogg (K) delivered earnings and revenue surprises of 4.12% and 4.52%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Should You Invest in the First Trust NASDAQ Food & Beverage ETF (FTXG)?
by Zacks Equity Research
Sector ETF report for FTXG
Why Earnings Season Could Be Great for Kellogg (K)
by Zacks Equity Research
Kellogg (K) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Hershey (HSY) Q3 Earnings Upcoming: Here's All You Should Note
by Zacks Equity Research
Hershey's (HSY) third-quarter 2022 performance will likely reflect gains from prudent acquisitions and strategic pricing efforts. However, rising cost inflation is likely to have been a concern.
Darling Ingredients (DAR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Darling (DAR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors to Affect Monster Beverage's (MNST) Q3 Earnings
by Zacks Equity Research
Monster Beverage's (MNST) Q3 results are expected to reflect the impacts of higher input costs and elevated freight. Strength in energy drinks and product launches are likely to have been upsides.
Medifast's (MED) Q3 Earnings Upcoming: Things Worth Noting
by Zacks Equity Research
Medifast's (MED) third-quarter 2022 results are likely to reflect cost-related challenges, whereas strength in the OPTAVIA lifestyle solution and coaching support system bodes well.
What Awaits The Estee Lauder Companies (EL) in Q1 Earnings?
by Zacks Equity Research
The Estee Lauder Companies (EL) Q1 performance will likely reflect adverse impacts from record inflation and supply chain disruptions. That said, strength in online sales is a breather.
Nu Skin (NUS) Queued for Q3 Earnings: Things to Consider
by Zacks Equity Research
Nu Skin's (NUS) Q3 performance will likely reflect continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.
Kellogg's (K) Q3 Earnings Upcoming: Here's All You Should Note
by Zacks Equity Research
Kellogg's (K) third-quarter 2022 results are likely to reflect gains from the company's revenue growth management actions, whereas cost inflation and supply-chain bottlenecks are likely to have been a concern.
Sysco's (SYY) Q1 Earnings Upcoming: Key Factors to Note
by Zacks Equity Research
Sysco's (SYY) first-quarter fiscal 2023 results are likely to reflect gains from the Recipe for Growth program and a diversified model, whereas high costs might have been a concern.
Service Corporation (SCI) to Report Q3 Earnings: Things to Note
by Zacks Equity Research
Service Corporation's (SCI) third-quarter 2022 performance will likely reflect the adverse impact of rising inflationary pressure. Strength in the funeral segment has been an upside.
Factors Likely to Influence Molson Coors' (TAP) Earnings in Q3
by Zacks Equity Research
Molson Coors' (TAP) Q3 results are likely to reflect gains from positive pricing and favorable brand and channel mix stemming from portfolio premiumization and reduced on-premise channel restrictions.
Here's Why Clorox (CLX) is Poised to Top Q1 Earnings Estimates
by Zacks Equity Research
Clorox's (CLX) first-quarter fiscal 2023 results are likely to reflect gains from the IGNITE strategy and pricing actions, whereas elevated inflation concerns are likely to have acted as deterrents.
Kellogg (K) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Kellogg (K) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.